Unknown

Dataset Information

0

Epoxygenase-Derived Epoxyeicosatrienoic Acid Mediators Are Associated With Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, and Fibrosis.

ABSTRACT:

SUBMITTER: Arvind A 

PROVIDER: S-EPMC7725909 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Epoxygenase-Derived Epoxyeicosatrienoic Acid Mediators Are Associated With Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, and Fibrosis.

Arvind Ashwini A   Osganian Stephanie A SA   Sjoquist Julia A JA   Corey Kathleen E KE   Simon Tracey G TG  

Gastroenterology 20200805 6

Similar Datasets

Unknown Circulating Citrate Is Associated with Liver Fibrosis in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.
| S-EPMC10487511 | biostudies-literature
Unknown The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis.
| S-EPMC4491606 | biostudies-literature
Unknown Human Liver-Derived Stem Cells Improve Fibrosis and Inflammation Associated with Nonalcoholic Steatohepatitis.
| S-EPMC6589210 | biostudies-literature
Unknown Macrophage MerTK Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis.
| S-EPMC7004886 | biostudies-literature
Unknown Current treatment options for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
| S-EPMC3378283 | biostudies-literature
Unknown Circulating Soluble CD163 is Associated with Steatohepatitis and Advanced Fibrosis in Nonalcoholic Fatty Liver Disease.
| S-EPMC4816035 | biostudies-literature
Unknown Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies.
| S-EPMC4208976 | biostudies-literature
Unknown Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis.
| S-EPMC6822168 | biostudies-literature
Unknown Steatohepatitis and liver fibrosis are predicted by the characteristics of very low density lipoprotein in nonalcoholic fatty liver disease.
| S-EPMC4942367 | biostudies-literature
Unknown Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
| S-EPMC6508084 | biostudies-literature